Antipsychotics with inverse agonist activity at the dopamine D3 receptor (Q42528940)

1 November 2017

title

Antipsychotics with inverse agonist activity at the dopamine D3 receptor (English)

1 reference

1 November 2017

N Griffon

1

1 reference

1 November 2017

C Pilon

2

1 reference

1 November 2017

F Sautel

3

1 reference

1 November 2017

J C Schwartz

4

1 reference

1 November 2017

P Sokoloff

5

1 reference

1 November 2017

publication date

1 January 1996

1 reference

Journal of Neural Transmission

1 November 2017

published in

1 reference

1 November 2017

volume

103

1 reference

1 November 2017

issue

10

1 reference

1 November 2017

page(s)

1163-1175

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01271201

1 November 2017

exact match

0 references

cites work

Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands

1 reference

12 December 2020

Constitutively active mutants of the alpha 2-adrenergic receptor

1 reference

12 December 2020

Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor

1 reference

12 December 2020

Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand

1 reference

12 December 2020

Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function

1 reference

12 December 2020

Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor

1 reference

12 December 2020

Expression and pharmacological characterization of the human D3 dopamine receptor

1 reference

12 December 2020

Stable expression of human D3 dopamine receptors in GH4C1 pituitary cells

1 reference

12 December 2020

Constitutively active mutants of rhodopsin

1 reference

12 December 2020

Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain.

1 reference

12 December 2020

Novel dopamine receptors half a decade later

1 reference

12 December 2020

Regulation of basal adenylate cyclase activity in neuroblastoma x glioma hybrid, NG108-15, cells transfected to express the human beta 2 adrenoceptor: evidence for empty receptor stimulation of the adenylate cyclase cascade

1 reference

12 December 2020

Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors

1 reference

12 December 2020

Inverse agonism: pharmacological curiosity or potential therapeutic strategy?

1 reference

12 December 2020

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

12 December 2020

A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty

1 reference

12 December 2020

A functional test identifies dopamine agonists selective for D3 versus D2 receptors.

1 reference

12 December 2020

Functional models for the dopamine D3 receptor

1 reference

12 December 2020

Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor

1 reference

12 December 2020

Inverse agonist activity of beta-adrenergic antagonists.

1 reference

12 December 2020

Characterization of the human dopamine D3 receptor expressed in transfected cell lines

1 reference

12 December 2020

Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation

1 reference

12 December 2020

Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas

1 reference

12 December 2020

Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors

1 reference

12 December 2020

Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism

1 reference

12 December 2020

Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness

1 reference

12 December 2020

Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line

1 reference

12 December 2020

The two-state model of receptor activation

1 reference

12 December 2020

A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor

1 reference

12 December 2020

Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents

1 reference

12 December 2020

The preferential dopamine D3 receptor ligand, (+)-UH232, is a partial agonist

1 reference

12 December 2020

Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function.

1 reference

12 December 2020

Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines

1 reference

12 December 2020

Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins

1 reference

12 December 2020

Mutations that alter the third cytoplasmic loop of the a-factor receptor lead to a constitutive and hypersensitive phenotype

1 reference

12 December 2020

High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype

1 reference

12 December 2020

A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01271201

1 reference

1 November 2017

1 reference